 |
인쇄하기
취소
|
Yuyu wins patent for new diabetic agent
Yuyu and CrystalGenomics announced on April 24 the acquisition of the local patent to cover a novel diabetic medication.
The patent invention relates to an inhibitor of glycogen synthase kinase-3 (GSK-3), its manufacturing method and pharmaceutical composition containing GSK-3.
Agents that inhibit GSK3 activity are useful in the treatment of disorders that are mediated by GSK3 activity.
...
The patent invention relates to an inhibitor of glycogen synthase kinase-3 (GSK-3), its manufacturing method and pharmaceutical composition containing GSK-3.
Agents that inhibit GSK3 activity are useful in the treatment of disorders that are mediated by GSK3 activity.
...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.